ANGUSTA

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Malta, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug ANGUSTA contains one active pharmaceutical ingredient (API):

1 Misoprostol UNII 0E43V0BB57 - MISOPROSTOL

Misoprostol is an analogue of naturally occurring prostaglandin E1 which promotes peptic ulcer healing and symptomatic relief. Misoprostol protects the gastroduodenal mucosa by inhibiting basal, stimulated and nocturnal acid secretion and by reducing the volume of gastric secretions, the proteolytic activity of the gastric fluid, and increasing bicarbonate and mucus secretion. Read about Misoprostol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ANGUSTA Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02AD06	Misoprostol	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02A Oxytocics → G02AD Prostaglandins
Discover more medicines within G02AD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1752533
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 044492
Country: FR	Base de données publique des médicaments	Identifier(s): 60213914
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 393906
Country: MT	Medicines Authority	Identifier(s): MA930/00401
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 206210
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100394154
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67698001